406 related articles for article (PubMed ID: 17488318)
1. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
2. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
3. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
4. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
Merlak M; Kovacević D; Balog T; Marotti T; Misljenović T; Mikulicić M; Dekaris I
Coll Antropol; 2008 Oct; 32 Suppl 2():39-43. PubMed ID: 19138004
[TBL] [Abstract][Full Text] [Related]
6. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
7. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
[TBL] [Abstract][Full Text] [Related]
10. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
[TBL] [Abstract][Full Text] [Related]
11. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
12. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
13. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
Duh EJ; Yang HS; Haller JA; De Juan E; Humayun MS; Gehlbach P; Melia M; Pieramici D; Harlan JB; Campochiaro PA; Zack DJ
Am J Ophthalmol; 2004 Apr; 137(4):668-74. PubMed ID: 15059706
[TBL] [Abstract][Full Text] [Related]
14. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
[TBL] [Abstract][Full Text] [Related]
15. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
16. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of monokine induced by interferon-gamma (Mig) in the vitreous of patients with diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Takeuchi M; Kezuka T; Iwasaki T; Goto H
Diabet Med; 2008 Jul; 25(7):875-7. PubMed ID: 18644076
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
Zhou H; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
[TBL] [Abstract][Full Text] [Related]
19. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.
Sonmez K; Drenser KA; Capone A; Trese MT
Ophthalmology; 2008 Jun; 115(6):1065-1070.e1. PubMed ID: 18031819
[TBL] [Abstract][Full Text] [Related]
20. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy.
Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS
Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]